These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18724156)

  • 41. The effect of the fourth-generation fluoroquinolones on corneal reepithelialization after penetrating keratoplasty.
    Moshirfar M; Marx DP; Kumar R
    Cornea; 2005 Oct; 24(7):833-6. PubMed ID: 16160500
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells.
    Ammar DA; Noecker RJ; Kahook MY
    Adv Ther; 2010 Nov; 27(11):837-45. PubMed ID: 20931366
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A new ophthalmic formulation containing antiseptics and dexpanthenol: In vitro antimicrobial activity and effects on corneal and conjunctival epithelial cells.
    Mencucci R; Favuzza E; Bottino P; Mazzantini C; Zanotto E; Pellegrini-Giampietro DE; Landucci E
    Exp Eye Res; 2020 Dec; 201():108269. PubMed ID: 32980315
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ocular penetration and pharmacokinetics of topical gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions after keratoplasty.
    Holland EJ; Lane SS; Kim T; Raizman M; Dunn S
    Cornea; 2008 Apr; 27(3):314-9. PubMed ID: 18362660
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cellular toxicity of calf blood extract on human corneal epithelial cells in vitro.
    Park YM; Kim SJ; Han YS; Lee JS
    Curr Eye Res; 2015 Jan; 40(1):66-71. PubMed ID: 24833044
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of TGF-β on ocular surface epithelial cells.
    Benito MJ; Calder V; Corrales RM; García-Vázquez C; Narayanan S; Herreras JM; Stern ME; Calonge M; Enríquez-de-Salamanca A
    Exp Eye Res; 2013 Feb; 107():88-100. PubMed ID: 23220729
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of corneal and aqueous humor penetration of moxifloxacin, gatifloxacin and levofloxacin during keratoplasty.
    Fukuda M; Yamada M; Kinoshita S; Inatomi T; Ohashi Y; Uno T; Shimazaki J; Satake Y; Maeda N; Hori Y; Nishida K; Kubota A; Nakazawa T; Shimomura Y
    Adv Ther; 2012 Apr; 29(4):339-49. PubMed ID: 22529026
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The successful treatment of gatifloxacin-resistant Staphylococcus aureus keratitis with Zymar (gatifloxacin 0.3%) in a NZW rabbit model.
    Romanowski EG; Mah FS; Yates KA; Kowalski RP; Gordon YJ
    Am J Ophthalmol; 2005 May; 139(5):867-77. PubMed ID: 15860293
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An evaluation of a cultured human corneal epithelial tissue model for the determination of the ocular irritation potential of pharmaceutical process materials.
    Seaman CW; Whittingham A; Guest R; Warren N; Olson MJ; Guerriero FJ; Adriaens E; De Wever B
    Toxicol In Vitro; 2010 Sep; 24(6):1862-70. PubMed ID: 20227483
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thymosin beta4 inhibits benzalkonium chloride-mediated apoptosis in corneal and conjunctival epithelial cells in vitro.
    Sosne G; Albeiruti AR; Hollis B; Siddiqi A; Ellenberg D; Kurpakus-Wheater M
    Exp Eye Res; 2006 Sep; 83(3):502-7. PubMed ID: 16630613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro toxicity of netilmicin and ofloxacin on corneal epithelial cells.
    Scuderi AC; Paladino GM; Marino C; Trombetta F
    Cornea; 2003 Jul; 22(5):468-72. PubMed ID: 12827054
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of gatifloxacin 0.3% or moxifloxacin 0.5% on corneal healing, ocular tolerability and toxicity following pterygium surgery.
    Mimouni M; Geffen N; Rosen E; Segev F
    Cutan Ocul Toxicol; 2016 Mar; 35(1):8-12. PubMed ID: 25597371
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antimicrobial efficacy of prophylactic gatifloxacin 0.3% and moxifloxacin 0.5% in patients undergoing phacoemulsification surgery.
    Bucci FA; Amico LM; Evans RE
    Eye Contact Lens; 2008 Jan; 34(1):39-42. PubMed ID: 18180682
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparison of fluoroquinolone penetration into human conjunctival tissue.
    Aihara M; Miyanaga M; Minami K; Miyata K; Eguchi S; Shiroma H; Sawaguchi S
    J Ocul Pharmacol Ther; 2008 Dec; 24(6):587-91. PubMed ID: 19049265
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of fluoroquinolone kinetics of kill in susceptible and resistant gram-positive conjunctival pathogens.
    D'Arienzo PA; Wagner RS; Jamison T; Bell B; Dajcs JJ; Stroman DW
    Adv Ther; 2010 Jan; 27(1):39-47. PubMed ID: 20174904
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the effects of fourth-generation fluoroquinolones on epithelial healing after photorefractive keratectomy.
    Shin JH; Lee HB; Park HY
    Cornea; 2010 Nov; 29(11):1236-40. PubMed ID: 20697276
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel in vivo rabbit model that mimics human dosing to determine the distribution of antibiotics in ocular tissues.
    Owen GR; Brooks AC; James O; Robertson SM
    J Ocul Pharmacol Ther; 2007 Aug; 23(4):335-42. PubMed ID: 17803431
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative minimal inhibitory and mutant prevention drug concentrations of four fluoroquinolones against ocular isolates of Haemophilus influenzae.
    Hedlin P; Blondeau JM
    Eye Contact Lens; 2007 May; 33(3):161-4. PubMed ID: 17502752
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effects of moxifloxacin ophthalmic solution 0.5% or gatifloxacin ophthalmic solution 0.3% treatment on corneal wound healing in pigmented rabbits following anterior keratectomy.
    Williams KK; McCartney MD; Rice RL; Wax MB; Hiddemen JW
    Vet Ophthalmol; 2008; 11(5):327-34. PubMed ID: 19046293
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety of intracameral injection of gatifloxacin, levofloxacin on corneal endothelial structure and viability.
    Choi JA; Chung SK
    J Ocul Pharmacol Ther; 2009 Oct; 25(5):425-31. PubMed ID: 19857104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.